{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T19:12:40Z","timestamp":1770059560084,"version":"3.49.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The aim of the present study was to investigate whether the disappearance of ischemic post-processing (IPO) in the myocardium of diabetes mellitus (DM) is associated with the increase of succinate dehydrogenase-flavin protein (SDHA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 50 Sprague Dawley rats, weighing 300\u2013400\u00a0g, were divided into 5 groups according to the random number table method, each with 10 rats. After DM rats were fed a high-fat and -sugar diet for 4\u00a0weeks, they were injected with Streptozotocin to establish the diabetic rat model. Normal rats were fed the same regular diet for the same number of weeks. Next, the above rats were taken to establish a cardiopulmonary bypass (CPB) model. Intraperitoneal glucose tolerance test (IPGTT) and oral glucose tolerance test (OGTT) were used to detect whether the DM rat model was established successfully. Taking blood from the femoral artery to collect the blood-gas analysis indicators, and judged whether the CPB model is established. After perfusion was performed according to the experimental strategy, the area of myocardial infarction (MI), and serum creatine kinase isoenzyme (CK-MB) and cardiac troponin (CTnI) levels were measured. Finally, the relative mRNA and protein expression of SDHA was detected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The OGTT and IPGTT suggested that the DM rat model was successfully established. The arterial blood gas analysis indicated that the CPB model was successfully established. As compared with the N group, the heart function of the IR group was significantly reduced, the levels of myocardial enzyme markers, the area of MI, as well as the relative mRNA and protein expression of SDHA, were all increased. As compared with the IR group, the CK-MB and CTnI levels in the IPO group, the MI area, relative mRNA and protein expression of SDHA decreased. As compared with the IPO group, the myocardial enzyme content in the DM\u2009+\u2009IPO group, the MI area and the relative mRNA and protein expression of SDHA increased. As compared with the DM\u2009+\u2009IPO group, in the DM\u2009+\u2009IPO\u2009+\u2009dme group, the myocardial enzyme content, area of MI and relative mRNA and protein expression were all decreased.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>IPO can inhibit the expression of SDHA, reduce MIRI and exert a cardioprotective effect in the normal rats. However, the protective effect of IPO disappears in the diabetic rats. The inhibitor dme combined with IPO can increase the expression of SDHA and restore the protective effect of IPO in DM myocardia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-021-01949-z","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T12:03:06Z","timestamp":1615982586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The disappearance of IPO in myocardium of diabetes mellitus rats is associated with the increase of succinate dehydrogenase-flavin protein"],"prefix":"10.1186","volume":"21","author":[{"given":"Mengyuan","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"issue":"7086","key":"1949_CR1","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nature04634","volume":"440","author":"N Houstis","year":"2006","unstructured":"Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440(7086):944\u20138.","journal-title":"Nature"},{"issue":"11","key":"1949_CR2","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/nrc3803","volume":"14","author":"SS Sabharwal","year":"2014","unstructured":"Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles\u2019 heel. Nat Rev Cancer. 2014;14(11):709\u201321.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"1949_CR3","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/ddr.21593","volume":"80","author":"NV Naryzhnaya","year":"2019","unstructured":"Naryzhnaya NV, Maslov LN, Oeltgen PR. Pharmacology of mitochondrial permeability transition pore inhibitors. Drug Dev Res. 2019;80(8):1013\u201330.","journal-title":"Drug Dev Res"},{"issue":"17","key":"1949_CR4","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1007\/s00018-016-2223-0","volume":"73","author":"A Loboda","year":"2016","unstructured":"Loboda A, Damulewicz M, Pyza E, Jozkowicz A, Dulak J. Role of Nrf2\/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73(17):3221\u201347.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1949_CR5","doi-asserted-by":"publisher","first-page":"16190","DOI":"10.1038\/s41598-017-16366-6","volume":"7","author":"Z Jia","year":"2017","unstructured":"Jia Z, Lian W, Shi H, et al. Ischemic postconditioning protects against intestinal ischemia\/reperfusion injury via the HIF-1\u03b1\/miR-21 Axis. Sci Rep. 2017;7(1):16190.","journal-title":"Sci Rep"},{"key":"1949_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12933-015-0313-1","volume":"14","author":"T Baranyai","year":"2015","unstructured":"Baranyai T, Nagy CT, Koncsos G, et al. Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning. Cardiovasc Diabetol. 2015;14:151.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"1949_CR7","doi-asserted-by":"publisher","first-page":"e86838","DOI":"10.1371\/journal.pone.0086838","volume":"9","author":"Z Han","year":"2014","unstructured":"Han Z, Cao J, Song D, et al. Autophagy is involved in the cardioprotection effect of remote limb ischemic postconditioning on myocardial ischemia\/reperfusion injury in normal mice, but not diabetic mice. PLoS ONE. 2014;9(1):e86838.","journal-title":"PLoS ONE"},{"issue":"5","key":"1949_CR8","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1016\/j.transproceed.2018.03.011","volume":"50","author":"Y Chen","year":"2018","unstructured":"Chen Y, Zhao L, Jiang S, et al. Cystathionine \u03b3-lyase is involved in the renoprotective effect of brief and repeated ischemic postconditioning after renal ischemia\/reperfusion injury in diabetes mellitus. Transplant Proc. 2018;50(5):1549\u201357.","journal-title":"Transplant Proc"},{"issue":"3","key":"1949_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.cardiores.2003.09.024","volume":"61","author":"DJ Hausenloy","year":"2004","unstructured":"Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res. 2004;61(3):448\u201360.","journal-title":"Cardiovasc Res"},{"issue":"6","key":"1949_CR10","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/jcmm.12369","volume":"19","author":"M Zhang","year":"2015","unstructured":"Zhang M, Sun D, Li S, et al. Lin28a protects against cardiac ischaemia\/reperfusion injury in diabetic mice through the insulin-PI3K-mTOR pathway. J Cell Mol Med. 2015;19(6):1174\u201382.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"1949_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13105-019-00664-w","volume":"75","author":"S Tyagi","year":"2019","unstructured":"Tyagi S, Singh N, Virdi JK, Jaggi AS. Diabetes abolish cardioprotective effects of remote ischemic conditioning: evidences and possible mechanisms. J Physiol Biochem. 2019;75(1):19\u201328.","journal-title":"J Physiol Biochem"},{"issue":"32","key":"1949_CR12","doi-asserted-by":"publisher","first-page":"11880","DOI":"10.1073\/pnas.0401703101","volume":"101","author":"H Ardehali","year":"2004","unstructured":"Ardehali H, Chen Z, Ko Y, Mej\u00eda-Alvarez R, Marb\u00e1n E. Multiprotein complex containing succinate dehydrogenase confers mitochondrial ATP-sensitive K+ channel activity. Proc Natl Acad Sci USA. 2004;101(32):11880\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1949_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/ATVBAHA.113.302131","volume":"34","author":"D Hamel","year":"2014","unstructured":"Hamel D, Sanchez M, Duhamel F, et al. G-protein-coupled receptor 91 and succinate are key contributors in neonatal postcerebral hypoxia-ischemia recovery. Arterioscler Thromb Vasc Biol. 2014;34(2):285\u201393.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1949_CR14","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/jpi.12269","volume":"59","author":"L Yu","year":"2015","unstructured":"Yu L, Liang H, Dong X, et al. Reduced silent information regulator 1 signaling exacerbates myocardial ischemia-reperfusion injury in type 2 diabetic rats and the protective effect of melatonin. J Pineal Res. 2015;59(3):376\u201390.","journal-title":"J Pineal Res"},{"issue":"5","key":"1949_CR15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.bbabio.2012.09.009","volume":"1827","author":"S Grimm","year":"2013","unstructured":"Grimm S. Respiratory chain complex II as general sensor for apoptosis. Biochim Biophys Acta. 2013;1827(5):565\u201372.","journal-title":"Biochim Biophys Acta"},{"issue":"7527","key":"1949_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani ET, Pell VR, Gaude E, et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature. 2014;515(7527):431\u20135.","journal-title":"Nature"},{"key":"1949_CR17","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s42255-019-0115-y","volume":"1","author":"JL Martin","year":"2019","unstructured":"Martin JL, Ashji SHC, Gruszczyk AV, et al. Succinate accumulation drives ischaemia-reperfusion injury during organ transplantation. Nat Metab. 2019;1:966\u201374.","journal-title":"Nat Metab."},{"issue":"3","key":"1949_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00395-019-0727-0","volume":"114","author":"M Kohlhauer","year":"2019","unstructured":"Kohlhauer M, Pell VR, Burger N, et al. Protection against cardiac ischemia-reperfusion injury by hypothermia and by inhibition of succinate accumulation and oxidation is additive. Basic Res Cardiol. 2019;114(3):18.","journal-title":"Basic Res Cardiol"},{"key":"1949_CR19","doi-asserted-by":"publisher","first-page":"e1706","DOI":"10.7717\/peerj.1706","volume":"4","author":"S Cao","year":"2016","unstructured":"Cao S, Liu Y, Wang H, et al. Ischemic postconditioning influences electron transport chain protein turnover in Langendorff-perfused rat hearts. PeerJ. 2016;4:e1706.","journal-title":"PeerJ"},{"issue":"4","key":"1949_CR20","doi-asserted-by":"publisher","first-page":"H281","DOI":"10.1152\/ajpheart.00666.2014","volume":"308","author":"Z Shi","year":"2015","unstructured":"Shi Z, Fu F, Yu L, et al. Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms. Am J Physiol Heart Circ Physiol. 2015;308(4):H281\u201390.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"1949_CR21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1024\/1661-8157\/a003188","volume":"108","author":"M Nemec","year":"2019","unstructured":"Nemec M. Interpretation of arterial blood gas analysis. Praxis. 2019;108(4):269\u201377.","journal-title":"Praxis"},{"issue":"2","key":"1949_CR22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.jss.2015.10.045","volume":"201","author":"K Charan","year":"2016","unstructured":"Charan K, Goyal A, Gupta JK, Yadav HN. Role of atrial natriuretic peptide in ischemic preconditioning-induced cardioprotection in the diabetic rat heart. J Surg Res. 2016;201(2):272\u20138.","journal-title":"J Surg Res"},{"issue":"3\u20134","key":"1949_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/1074248411402501","volume":"16","author":"RA Kloner","year":"2011","unstructured":"Kloner RA, Schwartz LL. State of the science of cardioprotection: challenges and opportunities\u2013proceedings of the 2010 NHLBI Workshop on cardioprotection. J Cardiovasc Pharmacol Ther. 2011;16(3\u20134):223\u201332.","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"1949_CR24","first-page":"115","volume":"23","author":"E Murphy","year":"2008","unstructured":"Murphy E, Steenbergen C. Ion transport and energetics during cell death and protection. Physiology (Bethesda). 2008;23:115\u201323.","journal-title":"Physiology (Bethesda)"},{"issue":"5","key":"1949_CR25","doi-asserted-by":"publisher","first-page":"H1723","DOI":"10.1152\/ajpheart.00553.2011","volume":"301","author":"S Sanada","year":"2011","unstructured":"Sanada S, Komuro I, Kitakaze M. Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol. 2011;301(5):H1723\u201341.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"1949_CR26","doi-asserted-by":"publisher","first-page":"H579","DOI":"10.1152\/ajpheart.01064.2002","volume":"285","author":"ZQ Zhao","year":"2003","unstructured":"Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285(2):H579\u201388.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"1949_CR27","doi-asserted-by":"publisher","first-page":"H364","DOI":"10.1152\/ajpheart.00369.2016","volume":"311","author":"EA Lambert","year":"2016","unstructured":"Lambert EA, Thomas CJ, Hemmes R, et al. Sympathetic nervous response to ischemia-reperfusion injury in humans is altered with remote ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2016;311(2):H364\u201370.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"1949_CR28","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1113\/EP085535","volume":"101","author":"M Donato","year":"2016","unstructured":"Donato M, Goyeneche MA, Garces M, et al. Myocardial triggers involved in activation of remote ischaemic preconditioning. Exp Physiol. 2016;101(6):708\u201316.","journal-title":"Exp Physiol"},{"issue":"6","key":"1949_CR29","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1159\/000452506","volume":"39","author":"J Zhu","year":"2016","unstructured":"Zhu J, Yao K, Wang Q, et al. Ischemic Postconditioning-regulated miR-499 protects the rat heart against ischemia\/reperfusion injury by inhibiting apoptosis through PDCD4. Cell Physiol Biochem. 2016;39(6):2364\u201380.","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"1949_CR30","first-page":"1506","volume":"37","author":"J Hu","year":"2017","unstructured":"Hu J, Gu XY, Meng Y, et al. Effect of dexmedetomidine postconditioning on myocardial ischemia-reperfusion injury and inflammatory response in diabetic rats. Nan Fang Yi Ke Da Xue Xue Bao. 2017;37(11):1506\u201311.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"1949_CR31","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ijbiomac.2018.11.190","volume":"125","author":"Y Shen","year":"2019","unstructured":"Shen Y, Liu X, Shi J, Wu X. Involvement of Nrf2 in myocardial ischemia and reperfusion injury. Int J Biol Macromol. 2019;125:496\u2013502.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"1949_CR32","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1159\/000491887","volume":"48","author":"J Xu","year":"2018","unstructured":"Xu J, Lin C, Wang T, Zhang P, Liu Z, Lu C. Ergosterol attenuates LPS-induced myocardial injury by modulating oxidative stress and apoptosis in rats. Cell Physiol Biochem. 2018;48(2):583\u201392.","journal-title":"Cell Physiol Biochem"},{"issue":"7","key":"1949_CR33","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.cell.2005.05.025","volume":"121","author":"F Sun","year":"2005","unstructured":"Sun F, Huo X, Zhai Y, et al. Crystal structure of mitochondrial respiratory membrane protein complex II. Cell. 2005;121(7):1043\u201357.","journal-title":"Cell"},{"key":"1949_CR34","doi-asserted-by":"publisher","first-page":"e1956","DOI":"10.1038\/cddis.2015.310","volume":"6","author":"R Dhingra","year":"2015","unstructured":"Dhingra R, Kirshenbaum LA. Succinate dehydrogenase\/complex II activity obligatorily links mitochondrial reserve respiratory capacity to cell survival in cardiac myocytes. Cell Death Dis. 2015;6:e1956.","journal-title":"Cell Death Dis"},{"issue":"7444","key":"1949_CR35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill GM, Curtis AM, Adamik J, et al. Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature. 2013;496(7444):238\u201342.","journal-title":"Nature"},{"issue":"2","key":"1949_CR36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/acn3.705","volume":"6","author":"L Guo","year":"2019","unstructured":"Guo L, Zhou D, Wu D, et al. Short-term remote ischemic conditioning may protect monkeys after ischemic stroke. Ann Clin Transl Neurol. 2019;6(2):310\u201323.","journal-title":"Ann Clin Transl Neurol"},{"key":"1949_CR37","unstructured":"Kr\u00e1snik V, \u0160tefani\u010dkov\u00e1 J, Fabkov\u00e1 J, Buckov\u00e1 D, Helbich M. [Prevalence of the diabetic retinopathy and genetic factors significance in the development of diabetic retinopathy in patients with diabetes mellitus type I and II in Slovakia (DIARET SK study). Overview of Actual Findings and Design of the Epidemiological DIARET SK Study]. Cesk Slov Oftalmol. 2015. 71(5): 237\u201342."},{"issue":"1","key":"1949_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12933-017-0628-1","volume":"16","author":"KB P\u00e6lestik","year":"2017","unstructured":"P\u00e6lestik KB, Jespersen NR, Jensen RV, Johnsen J, B\u00f8tker HE, Kristiansen SB. Effects of hypoglycemia on myocardial susceptibility to ischemia-reperfusion injury and preconditioning in hearts from rats with and without type 2 diabetes. Cardiovasc Diabetol. 2017;16(1):148.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"1949_CR39","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1007\/s00125-002-0882-x","volume":"45","author":"R Marfella","year":"2002","unstructured":"Marfella R, D\u2019Amico M, Di FC, et al. Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia. 2002;45(8):1172\u201381.","journal-title":"Diabetologia"},{"issue":"1","key":"1949_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12933-019-0872-7","volume":"18","author":"SB Kristiansen","year":"2019","unstructured":"Kristiansen SB, P\u00e6lestik KB, Johnsen J, et al. Impact of hyperglycemia on myocardial ischemia-reperfusion susceptibility and ischemic preconditioning in hearts from rats with type 2 diabetes. Cardiovasc Diabetol. 2019;18(1):66.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"1949_CR41","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/cvr\/cvs337","volume":"97","author":"RV Jensen","year":"2013","unstructured":"Jensen RV, Zachara NE, Nielsen PH, Kimose HH, Kristiansen SB, B\u00f8tker HE. Impact of O-GlcNAc on cardioprotection by remote ischaemic preconditioning in non-diabetic and diabetic patients. Cardiovasc Res. 2013;97(2):369\u201378.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"1949_CR42","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1161\/CIRCULATIONAHA.107.730515","volume":"117","author":"SP Jones","year":"2008","unstructured":"Jones SP, Zachara NE, Ngoh GA, et al. Cardioprotection by N-acetylglucosamine linkage to cellular proteins. Circulation. 2008;117(9):1172\u201382.","journal-title":"Circulation"},{"issue":"6","key":"1949_CR43","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1177\/1535370215622706","volume":"241","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhang L, Gu E, Zhu B, Zhao X, Chen J. Long-term insulin treatment restores cardioprotection induced by sufentanil postconditioning in diabetic rat heart. Exp Biol Med (Maywood). 2016;241(6):650\u20137.","journal-title":"Exp Biol Med (Maywood)"},{"key":"1949_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neuroscience.2018.09.041","volume":"393","author":"J Xu","year":"2018","unstructured":"Xu J, Pan H, Xie X, Zhang J, Wang Y, Yang G. Inhibiting succinate dehydrogenase by dimethyl malonate alleviates brain damage in a rat model of cardiac arrest. Neuroscience. 2018;393:24\u201332.","journal-title":"Neuroscience"},{"issue":"1","key":"1949_CR45","doi-asserted-by":"publisher","first-page":"10344","DOI":"10.1038\/s41598-020-67247-4","volume":"10","author":"NR Jespersen","year":"2020","unstructured":"Jespersen NR, Hjortbak MV, Lassen TR, et al. Cardioprotective effect of succinate dehydrogenase inhibition in rat hearts and human myocardium with and without diabetes mellitus. Sci Rep. 2020;10(1):10344.","journal-title":"Sci Rep"},{"issue":"5","key":"1949_CR46","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.2337\/diacare.27.5.1245","volume":"27","author":"J Drzewoski","year":"2004","unstructured":"Drzewoski J, Watala C. Is aspirin resistance a real problem in people with type 2 diabetes. Diabetes Care. 2004;27(5):1245\u20136.","journal-title":"Diabetes Care"},{"issue":"16","key":"1949_CR47","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1093\/eurheartj\/ehm248","volume":"28","author":"A Nicolucci","year":"2007","unstructured":"Nicolucci A, De Berardis G, Sacco M, Tognoni G. AHA\/ADA vs ESC\/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions. Eur Heart J. 2007;28(16):1925\u20137.","journal-title":"Eur Heart J."},{"issue":"1","key":"1949_CR48","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nm.2281","volume":"17","author":"HJ Bouman","year":"2011","unstructured":"Bouman HJ, Sch\u00f6mig E, van Werkum JW, et al. Paraoxonase-1 is a major determinant of clopidogrel efficacy. Nat Med. 2011;17(1):110\u20136.","journal-title":"Nat Med"},{"issue":"3","key":"1949_CR49","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1001\/archneur.62.3.403","volume":"62","author":"RL Sacco","year":"2005","unstructured":"Sacco RL, Sivenius J, Diener HC. Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations. Arch Neurol. 2005;62(3):403\u20138.","journal-title":"Arch Neurol"},{"issue":"2","key":"1949_CR50","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10557-012-6436-7","volume":"27","author":"XM Yang","year":"2013","unstructured":"Yang XM, Liu Y, Cui L, et al. Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts. Cardiovasc Drugs Ther. 2013;27(2):109\u201315.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"1949_CR51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1177\/1074248413508465","volume":"19","author":"MV Cohen","year":"2014","unstructured":"Cohen MV, Downey JM. Combined cardioprotectant and antithrombotic actions of platelet P2Y12 receptor antagonists in acute coronary syndrome: just what the doctor ordered. J Cardiovasc Pharmacol Ther. 2014;19(2):179\u201390.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"2","key":"1949_CR52","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10557-015-6633-2","volume":"30","author":"MV Cohen","year":"2016","unstructured":"Cohen MV, Yang XM, White J, Yellon DM, Bell RM, Downey JM. Cangrelor-mediated cardioprotection requires platelets and sphingosine phosphorylation. Cardiovasc Drugs Ther. 2016;30(2):229\u201332.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"7","key":"1949_CR53","doi-asserted-by":"publisher","first-page":"e71014","DOI":"10.1371\/journal.pone.0071014","volume":"8","author":"E Tuncay","year":"2013","unstructured":"Tuncay E, Okatan EN, Vassort G, Turan B. \u00df-blocker timolol prevents arrhythmogenic Ca2+ release and normalizes Ca2+ and Zn2+ dyshomeostasis in hyperglycemic rat heart. PLoS ONE. 2013;8(7):e71014.","journal-title":"PLoS ONE"},{"issue":"5","key":"1949_CR54","doi-asserted-by":"publisher","first-page":"665","DOI":"10.6061\/clinics\/2013(05)14","volume":"68","author":"JY Sun","year":"2013","unstructured":"Sun JY, Zhai L, Li QL, et al. Effects of ACE inhibition on endothelial progenitor cell mobilization and prognosis after acute myocardial infarction in type 2 diabetic patients. Clinics (Sao Paulo). 2013;68(5):665\u201373.","journal-title":"Clinics (Sao Paulo)"},{"issue":"10","key":"1949_CR55","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1161\/01.ATV.0000036417.43987.D8","volume":"22","author":"N Werner","year":"2002","unstructured":"Werner N, Priller J, Laufs U, et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol. 2002;22(10):1567\u201372.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"1949_CR56","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1172\/JCI200113152","volume":"108","author":"S Dimmeler","year":"2001","unstructured":"Dimmeler S, Aicher A, Vasa M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase\/Akt pathway. J Clin Invest. 2001;108(3):391\u20137.","journal-title":"J Clin Invest"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-01949-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-021-01949-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-01949-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T12:05:40Z","timestamp":1615982740000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-01949-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1949"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-01949-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"assertion":[{"value":"8 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the animal experimental ethics committee of ZunYi Medical University (approval No. ZMUER 2016-2-223). All animal experimental protocols mentioned in this study were in accordance with the Guide for the Care and Use of Laboratory Animals, published by the National Institute of Health (NIH publication 88.23, revised 1996). Sprague\u2013Dawley rats were purchased from Changsha Tianqin Biotechnology (HuNan, China) (License number: SCXK [Xiang] 2014-0011).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}